Abstract
We investigated the characteristics of patients with non-valvular atrial fibrillation (NVAF) and left atrial (LA) appendage (LAA) thrombus who had been given appropriate oral anticoagulation therapy. We studied 737 NVAF patients who were scheduled for catheter ablation or electrical cardioversion. All patients received appropriate oral anticoagulation therapy for at least 3 weeks prior to echocardiography in accordance with the guidelines. Whether LAA thrombus was present or absent on transesophageal echocardiography (TEE) was determined by at least three senior echocardiologists. LAA thrombi were observed in 22 patients (3.0%). Multivariate logistic regression analysis showed that LAA flow and LA volume index were both independent predictors of LAA thrombus formation; however, LAA flow (≤ 18 cm/s) was indicated as a more powerful predictor. Moreover, the prevalence of LAA thrombus formation in patients with NVAF without LA enlargement (LA volume index ≤ 34 mL/m2) was extremely rare (0.4%). LAA thrombus formation in patients with a mildly dilated LA volume index of 34–49.9 mL/m2 and paroxysmal AF was also extremely rare (0.0%). LAA flow is strongly associated with LAA thrombus formation, even in NVAF patients treated with appropriate oral anticoagulation therapy. Augmented oral anticoagulation therapy or transcatheter or surgical LAA closure should be considered for such patients, especially for those with an LAA flow < 18 cm/s. Furthermore, TEE for evaluating LAA thrombus before catheter ablation or electrical cardioversion may be unnecessary for NVAF patients who are undergoing appropriate oral anticoagulation therapy, depending on LA size.
Similar content being viewed by others
References
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952
Stewart S, Hart CL, Hole DJ, McMurray JJ (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113:359–364
Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492–501
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(2016):2893–2962
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al (2014) AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(2014):e1-76
Reers S, Karanatsios G, Borowski M, Kellner M, Reppel M, Waltenberger J (2018) Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis. Eur J Med Res 23:49
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373–498
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270
Andrade JG, Macle L, Nattel S, Verma A, Cairns J (2017) Contemporary atrial fibrillation management: a comparison of the current AHA/ACC/HRS, CCS, and ESC Guidelines. Can J Cardiol 33:965–976
Stoddard MF, Singh P, Dawn B, Longaker RA (2003) Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145:676–682
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713 (quiz 786-688)
Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:755–759
Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M et al (2018) Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 34:252–261
Wallace TW, Atwater BD, Daubert JP, Voora D, Crowley AL, Bahnson TD et al (2010) Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. J Cardiovasc Electrophysiol 21:849–852
Kawabata M, Goya M, Sasaki T, Maeda S, Shirai Y, Nishimura T et al (2017) Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy- Warfarin vs. direct oral anticoagulants. Circ J 81:645–651
Harada M, Koshikawa M, Motoike Y, Ichikawa T, Sugimoto K, Watanabe E et al (2018) Left atrial appendage thrombus prior to atrial fibrillation ablation in the era of direct oral anticoagulants. Circ J 82:2715–2721
Fatema K, Bailey KR, Petty GW, Meissner I, Osranek M, Alsaileek AA et al (2008) Increased left atrial volume index: potent biomarker for first-ever ischemic stroke. Mayo Clin Proc 83:1107–1115
Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289
Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR et al (2006) Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 47:1018–1023
Knight BP (2009) Transesophageal echocardiography before atrial fibrillation ablation: looking before cooking. J Am Coll Cardiol 54:2040–2042
Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S et al (2012) Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 60:531–538
Shimada M, Akaishi M, Kobayashi T (2020) Left atrial appendage morphology and cardiac function in patients with sinus rhythm. J Echocardiogr 18:117–124
Kishima H, Mine T, Ashida K, Sugahara M, Kodani T, Masuyama T (2015) Does left atrial appendage morphology influence left atrial appendage flow velocity? Circ J 79:1706–1711
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Hiroaki Shiraki, Hidekazu Tanaka, Yuki Yamauchi, Yuko Yoshigai, Kentaro Yamashita, Yusuke Tanaka, Keiko Sumimoto, Ayu Shono, Makiko Suzuki, Shun Yokota, Kensuke Matsumoto, Koji Fukuzawa, Ken-ichi Hirata declare that have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shiraki, H., Tanaka, H., Yamauchi, Y. et al. Characteristics of non-valvular atrial fibrillation with left atrial appendage thrombus who are undergoing appropriate oral anticoagulation therapy. Int J Cardiovasc Imaging 38, 941–951 (2022). https://doi.org/10.1007/s10554-021-02403-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-021-02403-z